Real-World Data By Design — Incorporating Different Data Types into Clinical Trials

Gaelan Ritter, Head, Innovation & Digital Health, BMS R&D Business Insights & Analytics, Bristol-Myers Squibb

As the head of Analytics Innovation and Digital Health, Gaelan and his team are responsible for creating and developing innovations across R&D. He co-leads the BMS digital innovation pillar for global drug development, which is enabling a spectrum of digital solutions, including several types of digital trial capabilities.

In past roles Gaelan has led and developed strategic partnerships with large academic medical centers and networks. He has also supported trial design and start-up for the BMS oncology and immunology programs. This experience led him to develop industry leading trial design software and processes that create digital protocols and feed downstream systems and processes. He is passionate about not only the ideation and creation, but the development and business change that creates lasting advancement in the industry.

Andrew Larsen, VP of Partnerships, PicnicHealth

Andrew Larsen is the VP of Partnerships at PicnicHealth and an industry leader in creating fit-for-purpose real-world data solutions. At PicnicHealth, he works with partners across the life sciences ecosystem to help advance disease understanding and support the development and access to innovative medicine for patients.

Prior to joining PicnicHealth, Andrew worked as a management consultant across leading and emerging biopharmaceutical companies to develop portfolio and asset strategies across all stages of development with a specialization in evidence generation needs. He has experience working across a broad range of therapeutic areas, including rare diseases and oncology, and Andrew received his Ph.D. from Johns Hopkins School of Medicine in Cellular and Molecular Medicine where his work focused on identifying new anticancer therapies and characterizing their mechanism of action.

Sneha Kishnani, Global Lead, RWE Decentralized Studies, IQVIA

Sneha is a certified PMP with over 15 years of industry-specific project management, risk planning & mitigation, and regulatory experience spanning all phases of the drug development lifecycle across a variety of therapeutic areas. As the Global Lead of the RWE Innovation Pillar of Decentralized Studies, her focus is to define the corporate innovation strategy for this pillar through strategic review and landscaping of industry trends and customer needs, engage key stakeholders and guide the ideation process to define and refine the existing innovative and strategic portfolio for Decentralized Studies.

In her nearly decade long tenure at IQVIA, Sneha has been responsible for providing Senior Oversight to cross-functional teams across a wide variety of therapeutic areas and study designs, with a special focus on rare disease, registries, and post-authorization safety studies. She’s also spent significant time serving as Partnership Lead across key strategic customer accounts, ensuring operational efficiencies and providing strategic consulting while building and bolstering strong, trusted customer relationships.

(Moderator) Evelyn Pyper, Evidence Strategist, PicnicHealth

Evelyn Pyper is Evidence Strategy Lead at PicnicHealth, a patient-centric real-world data company. Her career in Real World Evidence (RWE) spans the public and private sector as well as regional and global markets. Prior to PicnicHealth, she worked as Associate Director of Market Access at J&J Global Public Health, focused on securing access to HIV treatments in Sub-Saharan Africa; and as RWE Manager of a diverse portfolio of partnerships and research projects at Janssen Canada. Evelyn has a BHSc in Health Sciences with a minor in Psychology from McMaster University and a Master of Public Health (MPH) degree from Queen’s University. Evelyn is currently completing her doctorate (DPhil) in Evidence-Based Health Care at the University of Oxford, with a focus on digital health.